These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Informed consent. Trials that use Zelen's procedure should be acceptable. House A; Knapp P BMJ; 1997 Jul; 315(7102):251. PubMed ID: 9253287 [No Abstract] [Full Text] [Related]
44. Conducting stroke research with an exception from the requirement for informed consent. Bateman BT; Meyers PM; Schumacher HC; Mangla S; Pile-Spellman J Stroke; 2003 May; 34(5):1317-23. PubMed ID: 12663878 [TBL] [Abstract][Full Text] [Related]
45. Legal and ethical issues in clinical pharmacy research--informed consent, Part II. Foster TS; Raehl CL Drug Intell Clin Pharm; 1980 Feb; 14(2):122-5. PubMed ID: 10246117 [TBL] [Abstract][Full Text] [Related]
46. Clinical trials. How informed should consent be? Wolfe S RN; 2000 Jun; 63(6):77-82. PubMed ID: 10897755 [No Abstract] [Full Text] [Related]
47. Informed consent: an ethics question. Frelick RW Del Med J; 1988 Sep; 60(9):523-5. PubMed ID: 3181549 [No Abstract] [Full Text] [Related]
48. Elements of informed consent. Kachoyeanos MK MCN Am J Matern Child Nurs; 1996; 21(4):205. PubMed ID: 8754439 [No Abstract] [Full Text] [Related]
49. Is informed consent always needed? Warlow C Lancet; 1982 Dec; 2(8310):1280. PubMed ID: 6128577 [No Abstract] [Full Text] [Related]
50. Rigor in monitoring clinical trials is ethical. Piantadosi S J Clin Oncol; 2008 Feb; 26(4):683-5. PubMed ID: 18235132 [No Abstract] [Full Text] [Related]
51. Playing your part in a clinical trial. Dimsdale AW Nursing; 2006 Jul; 36(7):22-3. PubMed ID: 16816627 [No Abstract] [Full Text] [Related]
52. [(Informed consent in clinical trials and its impact on methods of randomization and statistical evaluation)]. Hildenbrand G; Baur MP; Hildenbrand K Onkologie; 1979 Dec; 2(6):221-5. PubMed ID: 398010 [TBL] [Abstract][Full Text] [Related]
53. [Informed consent. A myth--or a strait-jacket for policy control?]. Lunde PK Tidsskr Nor Laegeforen; 1992 Oct; 112(25):3181-2. PubMed ID: 1462287 [No Abstract] [Full Text] [Related]
58. Special challenges to the informed consent doctrine in the United States. Siegler M; Collins ME; Cronin DC J Clin Ethics; 2004; 15(1):38-47. PubMed ID: 15202356 [No Abstract] [Full Text] [Related]
59. A method to reduce loss to follow-up in clinical trials: informed, withdrawal of consent. Cleland JG; Torp-Pedersen C; Coletta AP; Lammiman MJ Eur J Heart Fail; 2004 Jan; 6(1):1-2. PubMed ID: 15012911 [No Abstract] [Full Text] [Related]
60. Informed consent in clinical trials of in vitro diagnostic devices: perspectives from the FDA and manufacturers. Moxey-Mims MM; Serge MJ; Melvin MN; Southwick PC; McCormack RT Clin Chem; 2001 Oct; 47(10):1753-7. PubMed ID: 11568082 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]